2MacKenzien N, Grant IS. Comparison of the new emulsion formulation of propofol with methohexitone and thiopentone for induction of anaesthesia in day cases. Br J Anaesth [J],1985, 5:725-731.
3Gin T, Gregory MA, Chan K, et al . Pharmacokinetics of propofol in women undergoing elective caesarean section[J]. Br J Anaesth, 1990, 64(2): 148-153.
2Mackenzie N, Grant IS. Comparison of the new emulsion formulation of propofol with methohexitone and thiopentone for induction of anaesthesia in day cases [J]. Br J Anaesth, 1985, 57: 725-731.
3Tallcy J J, Bertenshaw R, Brown DL, et al. N-[[(5-methyl- 3- phenylisoxazoI-4-yl)-phenyl] sulfonyl] propanamide, sodiumalt, pareeoxib sodium: a potent and selective inhibi- tor of COX-2 for parenteral administration [J]. J Med Chem, 2000, 43 : 1661-1663.
4Tong D, Chung F. Postoperative pain control in ambulatory surgery [J]. Surg Clin Norh Am, 1999, 79: 401-430.
5Dahl JB, Moniche S. Pre-emptive analgesia [J]. Br Med Bull, 2004, 71(1): 13-27.
6Talley JJ,Bertenshaw SR,Brown DL,et al.N-[(5-methyl-3-phenyli-soxazoI-4-y1)-pheny1]sulfonyl propanamide,sodiumalt,parecoxib so-dium:A potent and selective inhibitor of COX-2for parenteral admin-istration[J].J Med Chem,2000,43(9):1661-1663.
7Dahl JB,Moniche S.Pre-emptive analgesia[J].Br Med Bull,2004,71(1):13-27.
9Barakat AR, Sutcliffe N, Schwab M. Effect site concentration during propofol TCI sedation: a comparison of sedation score with two pharmacokinetic models [J]. Anesthesia, 2007, 62(7): 661-666.
10Paolo MP, Falzetti G, Pelaia P. Bispectral index and spectral entropy in neuroanesthesia [J]. J Neurosurg Anesthesiol, 2006, 18(3): 205-210.
